{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:40:55Z","timestamp":1787503255609,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Res Med Sci"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/1735-1995.172983","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T04:38:04Z","timestamp":1451536684000},"page":"1160","source":"Crossref","is-referenced-by-count":13,"title":["A comparative study of vaginal estrogen cream and sustained-release estradiol vaginal tablet (Vagifem) in the treatment of atrophic vaginitis in Isfahan, Iran in 2010-2012"],"prefix":"10.4103","volume":"20","author":[{"given":"Pardis","family":"Hosseinzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atallah","family":"Ghahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freshteh","family":"Daneshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1735-1995.172983-1","first-page":"149","volume-title":"The effects of oestrogen on urogenital health","author":"Lachowsky","year":"2009","journal-title":"Maturitas"},{"key":"key-10.4103\/1735-1995.172983-2","first-page":"S21","volume-title":"The estradiol vaginal ring - a study of existing clinical data","author":"Bachmann","year":"1995","journal-title":"Maturitas"},{"key":"key-10.4103\/1735-1995.172983-3","doi-asserted-by":"crossref","unstructured":"Griesser H, Skonietzki S, Fischer T, Fielder K, Suesskind M. Low dose estriol pessaries for the treatment of vaginal atrophy: A double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2 mg and 0.03 mg estriol. Maturitas 2012;71:360-8.","DOI":"10.1016\/j.maturitas.2011.12.022"},{"key":"key-10.4103\/1735-1995.172983-4","first-page":"3090","volume-title":"Diagnosis and treatment of atrophic vaginitis","author":"Bachmann","year":"2000","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/1735-1995.172983-5","first-page":"503","volume-title":"The detection and management of vaginal atrophy","author":"Johnston","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"key-10.4103\/1735-1995.172983-6","first-page":"293","volume-title":"Comparison of usefulness of stradiol vaginal tablets and estriol vagitories for treatment of vaginalatrophy","author":"Dugal","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key-10.4103\/1735-1995.172983-7","first-page":"255","volume-title":"The effect of Estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: A comparative study","author":"Manonai","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"key":"key-10.4103\/1735-1995.172983-8","first-page":"355","volume-title":"The role of local vaginal estrogen for treatment of vaginal atrophyi n postmenopausal women: 2007 position statement of The North American Menopause Society","author":"North","year":"2007","journal-title":"Menopause"},{"key":"key-10.4103\/1735-1995.172983-9","first-page":"666","volume-title":"Vaginal estrogens for the treatment of dyspareunia","author":"Krychman","year":"2011","journal-title":"J Sex Med"},{"key":"key-10.4103\/1735-1995.172983-10","first-page":"4","volume-title":"Gynecologic issues in geriatric women","author":"Stiles","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.4103\/1735-1995.172983-11","first-page":"85","volume-title":"Perception and use of local hormone replacement therapy","author":"Calaf","year":"1996","journal-title":"Eur J Menopause"},{"key":"key-10.4103\/1735-1995.172983-12","first-page":"719","volume-title":"Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally","author":"Bachmann","year":"2009","journal-title":"Menopause"},{"key":"key-10.4103\/1735-1995.172983-13","first-page":"67","volume-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: A randomized controlled trial","author":"Bachmann","year":"2008","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/1735-1995.172983-14","first-page":"215","volume-title":"Vaginal administration of low-dose conjugated estrogens: Systemic absorption and effects on the endometrium","author":"Handa","year":"1994","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/1735-1995.172983-15","first-page":"753","volume-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections","author":"Raz","year":"1993","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1735-1995.172983-16","unstructured":"Nordisk Novo. Vagifem 10 mcg to replace Vagifem 25 mcg Formulation for Atrophic Vaginitis Due to Menopause. Available from: http:\/\/press.novonordisk-us.com. [Last accessed on 2010 Oct 7]."},{"key":"key-10.4103\/1735-1995.172983-17","first-page":"257","volume-title":"Vagifem TM vs Premarin A vaginal cream: Efficacy and safety in women with estrogen deficiency-derived atrophic vaginitis","author":"Devlin","year":"1998","journal-title":"Menopause"},{"key":"key-10.4103\/1735-1995.172983-18","first-page":"156","volume-title":"17 beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis","author":"Rioux","year":"2000","journal-title":"Menopause"},{"key":"key-10.4103\/1735-1995.172983-19","first-page":"556","volume-title":"Estradiol absorption from vaginal tablets in Postmenopausal women","author":"Notelovitz","year":"2002","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/1735-1995.172983-20","first-page":"1053","volume-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet","author":"Simon","year":"2008","journal-title":"Obstet Gynecol"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:29:09Z","timestamp":1786649349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1735-1995.172983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"alternative-id":["172983"],"URL":"https:\/\/doi.org\/10.4103\/1735-1995.172983","relation":{},"ISSN":["1735-1995"],"issn-type":[{"value":"1735-1995","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}